drugset / Trial / NCT02002039

Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

NCT02002039

Phase 2/3 Completed 100 enrolled Sheri Kashmir Institute of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

Whether Erythropoietin improves the neurological outcomes of neonates with perinatal asphyxia.

Timeline

Start
2012-06
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic 500 iu/kg

Indications